Small dense low‐density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease
Open Access
- 7 March 2018
- journal article
- research article
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 18 (6) , 965-972
Abstract
Aim: The study objective was to investigate whether small dense low‐density lipoprotein cholesterol (sdLDL‐C) is superior to low‐density lipoprotein cholesterol (LDL‐C) and other biomarkers to predict future cardiovascular events (CE) in secondary prevention.Methods: sdLDL‐C measured by a homogeneous assay, remnant lipoprotein cholesterol, LDL particle diameter and other biomarkers were compared in 345 men aged ≥65 years with stable coronary artery disease. Baseline LDL‐C was 100.5 ± 30.1 mg/dL. CE including cardiovascular death, onset of acute coronary syndrome, need for arterial revascularization, hospitalization for heart failure, surgery procedure for cardiovascular disease and hospitalization for stroke were monitored for 5 years.Results: CE occurred in 96 patients during the study period. LDL‐C, sdLDL‐C non‐high‐density lipoprotein cholesterol, apolipoprotein B, remnant lipoprotein cholesterol, glucose, glycated hemoglobin and brain natriuretic peptide were significantly higher; LDL particle diameter and apolipoprotein A‐1 were significantly lower in patients with than in those without CE. Age‐adjusted Cox regression analysis showed that sdLDL‐C per 10 mg/dL, but not LDL‐C, was significantly associated with CE (HR 1.206, 95% CI 1.006–1.446). A significant association of sdLDL‐C and incident CE was observed in statin users (HR 1.252, 95% CI 1.017–1.540), diabetes patients (HR 1.219, 95% CI 1.018–1.460), patients without diabetes (HR 1.257, 95% CI 1.019–1.551) and patients with hypertriglyceridemia (HR 1. 376, 95% CI 1.070–1.770).Conclusions: sdLDL‐C was the most effective predictor of residual risk of future CE in stable coronary artery disease patients using statins and in high‐risk coronary artery disease patients with diabetes or hypertriglyceridemia. Geriatr Gerontol Int 2018; 18: 965–972.Keywords
This publication has 25 references indexed in Scilit:
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsJAMA, 2012
- Non‐high‐density lipoprotein cholesterol: An important predictor of stroke and diabetes‐related mortality in Japanese elderly diabetic patientsGeriatrics & Gerontology International, 2012
- Evaluation of a new homogenous method for detection of small dense LDL cholesterol: Comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugationClinica Chimica Acta, 2011
- Development of a Homogeneous Assay for Measurement of Small Dense LDL CholesterolClinical Chemistry, 2011
- Prevalence of chronic kidney disease in the Japanese general populationClinical and Experimental Nephrology, 2009
- Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseasesAtherosclerosis, 2006
- Increased ApoB in Small Dense LDL Particles Predicts Premature Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Metabolic origins and clinical significance of LDL heterogeneityJournal of Lipid Research, 2002
- Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gelsClinica Chimica Acta, 1993
- [24] Nondenaturing polyacrylamide gradient gel electrophoresis1986